Efficacy of Platinum-Based Chemotherapy for Relapsed Small-Cell Lung Cancer after Amrubicin Monotherapy in Elderly Patients and Patients with Poor Performance Status-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of Platinum-Based Chemotherapy for Relapsed Small-Cell Lung Cancer after Amrubicin Monotherapy in Elderly Patients and Patients with Poor Performance Status

Published:2018 Issue:4 Volume:94 Page:207-214
ISSN:0030-2414
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Igawa Satoshi,Shirasawa Masayuki,Fukui Tomoya,Nishinarita Noriko,Sone Hideyuki,Ozawa Takahiro,Sugita Keisuke,Okuma Yuriko,Kurahayashi Shintaro,Ono Taihei,Sugimoto Ai,Mitsufuji Hisashi,Kubota Masaru,Katagiri Masato,Sasaki Jiichiro,Naoki Katsuhiko

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment patterns and outcomes among patients with small-cell lung cancer (SCLC) in Europe: a retrospective cohort study;BMJ Open;2023-02

2. Pharmacokinetics and safety of lobaplatin plus etoposide in Chinese men older than 65 years with extensive-stage small cell lung cancer: a phase II clinical trial;Cancer Chemotherapy and Pharmacology;2019-04-30

3. Recombinant human arginase induces apoptosis through oxidative stress and cell cycle arrest in small cell lung cancer;Cancer Science;2018-10-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP